Filter Results:
(816)
Show Results For
- All HBS Web
(1,402)
- People (1)
- News (333)
- Research (816)
- Events (1)
- Multimedia (8)
- Faculty Publications (593)
Show Results For
- All HBS Web
(1,402)
- People (1)
- News (333)
- Research (816)
- Events (1)
- Multimedia (8)
- Faculty Publications (593)
Sort by
- March 2015 (Revised November 2017)
- Case
Bonitas
By: Regina E. Herzlinger and Natalie Kindred
Bonitas, a South African medical scheme (i.e., health insurer), must navigate highly restrictive regulations that make it difficult for Bonitas to innovate, grow, and compete with market leader Discovery as well as providers of alternative insurance products. Bonitas... View Details
Keywords: Health Insurance; Health Care; South Africa; Medical Scheme; Public Policy; Bonitas; Bonitas Medical Fund; National Health Insurance; Health; Health Care and Treatment; Insurance; Policy; Health Industry; Health Industry; South Africa; Johannesburg; Africa
Herzlinger, Regina E., and Natalie Kindred. "Bonitas." Harvard Business School Case 315-020, March 2015. (Revised November 2017.)
- October 2017
- Case
Pricing PatientPing
By: Frank V. Cespedes, Julia Kelley and Amram Migdal
In 2017, Jay Desai, the CEO of Boston-based health care technology company PatientPing, had to consider a number of interrelated pricing challenges. Founded in late 2013, PatientPing sold a software platform that allowed health care providers to receive real-time... View Details
Keywords: Pricing; Health Tech; Health Technology; Marketing; Sales Process; Sales Strategy; Price; Sales; Marketing Strategy; Health Care and Treatment; Health Industry; Health Industry; Boston; North America; Massachusetts; United States
Cespedes, Frank V., Julia Kelley, and Amram Migdal. "Pricing PatientPing." Harvard Business School Case 818-017, October 2017.
- June 2024
- Article
It Is Time to Consider More Price Regulation in Health Care
By: Sherry Glied and Amitabh Chandra
Glied, Sherry, and Amitabh Chandra. "It Is Time to Consider More Price Regulation in Health Care." JAMA Health Forum 5, no. 6 (June 2024).
- January 2021
- Article
COVID-19 Hasn't Been a Tipping Point for Value-Based Care, but It Should Be
By: Thomas W. Feeley
Four out of five health care provider organizations are suffering ongoing losses as a result of the
COVID-19 pandemic, according to the recent NEJM Catalyst Insights Council survey on value-based
payment and care. Yet Council members, who are still largely entrenched... View Details
Feeley, Thomas W. "COVID-19 Hasn't Been a Tipping Point for Value-Based Care, but It Should Be." NEJM Catalyst Innovations in Care Delivery 2, no. 1 (January 2021).
- June 2008 (Revised January 2010)
- Supplement
Name Your Price: Compensation Negotiation at Whole Health Management (C)
By: Brian J. Hall, Deepak Malhotra and Nicole Bennett
Supplements the (A) and (B) cases. View Details
Hall, Brian J., Deepak Malhotra, and Nicole Bennett. "Name Your Price: Compensation Negotiation at Whole Health Management (C)." Harvard Business School Supplement 908-066, June 2008. (Revised January 2010.)
- February 2019
- Article
Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
By: David Cutler, Jonathan Skinner, Ariel Dora Stern and David Wennberg
There is considerable controversy about the causes of regional variations in health care expenditures. Using vignettes from patient and physician surveys linked to fee-for-service Medicare expenditures, this study asks whether patient demand-side factors or physician... View Details
Cutler, David, Jonathan Skinner, Ariel Dora Stern, and David Wennberg. "Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending." American Economic Journal: Economic Policy 11, no. 1 (February 2019): 192–221.
- October 10, 2019
- Article
The Case for the Public Option Over Medicare for All
By: Regina E. Herzlinger and Richard Boxer
How can the United States better control its health care costs and quality and still achieve universal coverage? The strongest choice is not Medicare for All, which would eliminate private insurance; it’s the public option, which would allow people to choose from... View Details
Keywords: Universal Health Coverage; Public Option; Medicare; Health Care and Treatment; Insurance; Cost Management; Quality; United States
Herzlinger, Regina E., and Richard Boxer. "The Case for the Public Option Over Medicare for All." Harvard Business Review Digital Articles (October 10, 2019): 2–5.
- Article
Disruptive Innovation: A New Diagnosis for Health Care's 'Financial Flu'
By: John Kenagy and C. M. Christensen
Kenagy, John, and C. M. Christensen. "Disruptive Innovation: A New Diagnosis for Health Care's 'Financial Flu'." hfm (Healthcare Financial Management) 56, no. 5 (May 2002): 62–66.
- July 2020
- Case
King's College Hospital in Crisis
By: John R. Wells and Benjamin Weinstock
On December 11, 2017, King’s College Hospital NHS Foundation Trust (King’s), one of London’s leading teaching hospital groups, was put into “special measures” by NHS Improvement (NHSI), the financial regulator of England’s National Health Service (NHS). The future of... View Details
Keywords: Hospitals; Financing; Health Care and Treatment; Financial Condition; Crisis Management; Organizational Structure; Transformation; Strategic Planning; United Kingdom
Wells, John R., and Benjamin Weinstock. "King's College Hospital in Crisis." Harvard Business School Case 721-356, July 2020.
- Article
Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth
By: Leemore S. Dafny, Igal Hendel, Victoria Marone and Christopher Ody
Anecdotal reports and systematic research highlight the prevalence of narrow-network plans on the Affordable Care Act’s health insurance Marketplaces. At the same time, Marketplace premiums in the period 2014–2016 were much lower than projected by the Congressional... View Details
Dafny, Leemore S., Igal Hendel, Victoria Marone, and Christopher Ody. "Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth." Health Affairs 36, no. 9 (September 2017).
- 2012
- Report
Better Outcomes, Lower Costs: A Conversation with Dr. Atul Gawande
By: Mark R. Kramer
In the face of increasing health care costs and uncertainty about health care quality in the United States, community-based collective impact initiatives driven by regional funders offers a new way to improve patient outcomes at the local level. Collectively,... View Details
Keywords: Community Foundations; Health Outcomes; Health Care and Treatment; Quality; Cost Management; United States
Kramer, Mark R. "Better Outcomes, Lower Costs: A Conversation with Dr. Atul Gawande." Report, FSG, 2012.
- January 19, 2024
- Article
Value-Based Health Care Can Transform the Treatment of Patients with Substance Use Disorder
By: Robert S. Kaplan and Sarah E. Wakeman
U.S. overdose deaths currently exceed 100,000 per year. New facilities, known as bridge clinics, are broadening access to high-quality care by offering outpatient substance use disorder (SUD) treatment with few access barriers. But many of the critical services offered... View Details
Kaplan, Robert S., and Sarah E. Wakeman. "Value-Based Health Care Can Transform the Treatment of Patients with Substance Use Disorder." Health Affairs Forefront (January 19, 2024).
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A bipartisan combination of the two parties’ most popular initiatives can expand health care coverage, significantly reduce costs, and enable freedom of choice, without raising taxes. Along the way, we can revitalize competition between public and private plans. Our... View Details
Keywords: Health Insurance; Public Option; Health Care and Treatment; Insurance; Cost Management; United States
Herzlinger, Regina E., and Richard Boxer. "How to Pay for Public Option Without Tax Hike." RealClearPolicy (September 2, 2020).
- May 1994 (Revised February 2021)
- Background Note
Note on Reimbursement of Health Care Providers: Case-Based and Capitation Payment
By: Regina E. Herzlinger and Tom Nagle
Explains how managed care organizations use capitation as a payment method for providers. View Details
Keywords: Managed Care; Capitation; Health Care and Treatment; Insurance; Accounting; Financial Management; Health Industry; Health Industry
Herzlinger, Regina E., and Tom Nagle. "Note on Reimbursement of Health Care Providers: Case-Based and Capitation Payment." Harvard Business School Background Note 194-141, May 1994. (Revised February 2021.)
- March 2021
- Supplement
Humana (C) — Reorganization
By: Regina E. Herzlinger and Ashley Ifeadike
A summary of Humana's restructuring of its business around its pillars. View Details
Keywords: Health Care; Health Care Industry; Health Insurance; Health Care Operations; Health; Health Care and Treatment; Insurance; Operations; Restructuring; Health Industry
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (C) — Reorganization." Harvard Business School Supplement 321-122, March 2021.
- March 2021
- Case
Humana (A)
By: Regina E. Herzlinger and Ashley Ifeadike
To implement a bold new strategy, Humana needed to decide how to prioritize the pillars; where to own and where to partner; how much risk is acceptable; and how to continue to deliver strong operational performance while implementing a new strategy. Had the firm made... View Details
Keywords: Health ＆ Wellness; Health Care Industry; Health Care Costs; Health Insurance; Health Insurance Marketplaces; Health Care and Treatment; Cost; Insurance; Strategy; Health Industry; United States
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (A)." Harvard Business School Case 321-097, March 2021.
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Health Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- September 2020 (Revised January 2021)
- Case
Catalys Pacific
In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After... View Details
Keywords: Pharmaceutical Companies; Biotech; Health Care; Entrepreneur; Innovation; International Business; Entrepreneurial Finance; Entrepreneurship; Finance; Innovation Strategy; Venture Capital; Strategy; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; Biotechnology Industry; Tokyo
Krieger, Joshua Lev. "Catalys Pacific." Harvard Business School Case 821-035, September 2020. (Revised January 2021.)
- June 2024 (Revised December 2024)
- Case
Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital
By: Joshua D. Margolis and Ahmed Dahawy
Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture arm as well as progress her own career. Over the past few years Hikma's executive team had been pressuring the... View Details
Keywords: Business Divisions; Corporate Entrepreneurship; Investment; Corporate Governance; Health Care and Treatment; Leadership Development; Business or Company Management; Growth and Development Strategy; Business Strategy; Venture Capital; Personal Development and Career; Health Industry; Health Industry; Jordan
Margolis, Joshua D., and Ahmed Dahawy. "Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital." Harvard Business School Case 424-075, June 2024. (Revised December 2024.)
- August 14, 2020
- Comment
How Has COVID-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey
By: Leemore S. Dafny, Yin Wei Soon, Zoë Cullen and Christopher T. Stanton
As the COVID-19 pandemic stretches toward its third quarter, loss of health insurance coverage has not figured prominently in the public debate. Data in this report demonstrate why that is, but also suggest that the apparent stability is fragile, with potentially... View Details
Keywords: Health Pandemics; Health Care and Treatment; Insurance; Small Business; Surveys; United States
Dafny, Leemore S., Yin Wei Soon, Zoë Cullen, and Christopher T. Stanton. "How Has COVID-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey." NEJM Catalyst (August 14, 2020). (Commentary.)